For Cancer Caregivers, the Dread of Future Costs Harms Health 8 Times More Than Actual Bills
For many families navigating a parent or loved one’s cancer diagnosis, sleepless nights become the new normal.
Search results for "Toxicity"
From Relief to Toxicity: The Hidden Danger of Mixing Common Cold Medications
Many households keep a stock of leftover cold medicines, often accumulating various brands over time. When symptoms like a cough or fever return, it...
When Supplements Turn Toxic: The Hidden Risks of Over-Dosing on Calcium and Vitamin D
While nutrients found in natural foods rarely cause significant side effects even when consumed in large amounts,...
'This Supplement' - Taking Too Many Supplements Can Lead to Liver Toxicity, Gastrointestinal Disorders, and Flushing
These days, various supplements are overflowing. Is it because people are not satisfied with foods containing vitamins...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors
When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
Yuhan Ramps Up OTC Magnesium Push with Dual-Campaign for Liquid and High-Dose 'MagV'
If your lower eyelid twitches or you experience sudden leg cramps, it is common to assume a magnesium deficiency is to...
AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy
Researchers are launching an international joint study that leverages artificial intelligence to evaluate whether...
Prevention vs. Treatment: Why Cancer Therapy Demands a Completely Different Diet
What makes diabetes particularly dangerous is the risk of severe, systemic complications.
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...